NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

[profilepress-login id="1"]

Don't have an account? Subscribe

Ulster University part of £750,000 CF-related diabetes study

By Dermot - 05th Aug 2016

Ulster University will play a key role in the research, which is being led by Newcastle University (UK) in partnership with Lund University (Sweden), The University of Iowa (USA) and Szeged University (Hungary).

“Discovering how the defective cystic fibrosis gene affects the body’s ability to regulate insulin levels is crucial to working out how to prevent diabetes from developing in CF sufferers,” said Dr Catriona Kelly from Ulster University.

“This new research brings CF and diabetes specialists together for the first time to identify crucial new treatment options that could enable the majority of CF patients to live longer and healthier lives.

“Ulster University’s specialist expertise in personalised medicine research carried out at our C-TRIC facility in Altnagelvin will be integral to the study.”

Approximately 20 per cent of adolescents and 50 per cent of adults living with CF have diabetes, and the condition can have a detrimental impact on lung function and wider health.

Known as Cystic fibrosis-related diabetes (CFRD), it is a unique condition. While the cause is unknown, the development of the diabetes accelerates lung disease, which is the main reason for death among people with CF.

Leave a Reply

Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read